Myriad Genetics Elevates Ben Wheeler to CFO Role Amid Growth
Myriad Genetics Announces New Chief Financial Officer
Myriad Genetics, Inc. (NASDAQ: MYGN), known for its leadership in molecular diagnostic testing and precision medicine, has recently made a pivotal decision to promote Ben Wheeler to the position of Chief Financial Officer. This change is effective immediately, reinforcing the company's commitment to enhancing its financial strategy and operational efficiency.
Ben Wheeler's Journey Within Myriad Genetics
Wheeler's impressive journey with Myriad began over 13 years ago when he joined as the assistant controller in December 2011. His career within the company has seen him climb through various leadership roles. Prior to his current promotion, he served as the vice president and corporate controller, followed by a role as senior vice president of accounting. Since 2022, he has contributed significantly as the chief financial officer for operations.
Leadership Transition and Future Impact
Scott Leffler, who held the Chief Financial Officer position since January 2024, is set to transition into a consulting role. He will focus on supporting the CEO and the Board of Directors until early September, allowing for a smooth transfer of responsibilities. In comments about this transition, Sam Raha, the President and CEO, expressed gratitude to Leffler for his valuable contributions and shared optimism for Wheeler's leadership. “Ben’s extensive knowledge of our business and financial acumen will be instrumental in advancing our profitable growth strategy,” he stated.
Wheeler’s Vision for Myriad Genetics
Wheeler shared his enthusiasm about taking on this pivotal role within Myriad’s finance team. He is poised to play a significant part in the advancement of the company’s mission and long-term strategy. “I look forward to collaborating with Sam and the executive team to not only impact more patient lives but also to create sustainable value for our shareholders,” he said.
Resilience in Financial Guidance
Myriad Genetics is reaffirming its financial guidance for the full-year 2025, which was initially discussed in their earnings call earlier this quarter. This reaffirms the company’s confidence in its financial health and trajectory.
About Myriad Genetics
As a cornerstone in the molecular diagnostic landscape, Myriad Genetics is dedicated to advancing healthcare through innovative testing solutions. The company creates and offers molecular tests designed to evaluate disease risk and guide treatment decisions across different medical specialties, ultimately aiming to enhance patient care and reduce associated healthcare costs. For further insights about Myriad, please visit www.myriad.com.
Investor and Media Contacts
Investor Contact:
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact:
Kate Schraml
(224) 875-4493
PR@myriad.com
Frequently Asked Questions
Who is Ben Wheeler?
Ben Wheeler is the newly appointed Chief Financial Officer of Myriad Genetics, having been with the company for over 13 years.
What was Ben Wheeler's role before becoming CFO?
Before his promotion to CFO, he served as the chief financial officer of operations and held various leadership roles within Myriad.
What is the significance of Scott Leffler's transition?
Scott Leffler will move to a consulting role, facilitating a smooth transition while allowing for continuity in leadership at Myriad Genetics.
What is Myriad Genetics known for?
Myriad Genetics is recognized for its expertise in molecular diagnostic testing and precision medicine, aimed at improving patient outcomes.
What are Myriad's financial expectations for 2025?
The company has reaffirmed its financial guidance for the full-year 2025, showcasing confidence in its continued growth.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
